Abstract

This review aims to examine the tobacco and nicotine industry’s “harm reduction” narrative through historical, toxicological, behavioral, and environmental dimensions, and to critically evaluate whether electronic cigarettes can genuinely be considered a harm-reduction tool within tobacco control.

This review was designed as a critical narrative and analytical synthesis. A structured literature search was conducted in the PubMed, Scopus, and Web of Science databases to identify English-language studies published between 2010 and 2025. The search strategy included the terms “electronic cigarettes,” “vaping,” “electronic nicotine delivery systems (ENDS),” “heated tobacco products,” “nicotine pouches,” “harm reduction,” “dual use,” “youth initiation,” and “tobacco industry.” To capture respiratory health outcomes, additional keywords such as “lung,” “pulmonary,” “airway,” “respiratory,” “EVALI,” and “vaping-associated lung injury” were incorporated.

Studies reporting findings in favor of harm reduction, particularly those funded by or affiliated with the tobacco or nicotine industry, were critically appraised and systematically contrasted with independent research to assess potential sources of bias and divergence in interpretation.

Historically, tobacco has been legitimized through narratives suggesting it is a “less harmful” or even “protective” product—an approach that is currently replicated for e-cigarettes, heated tobacco products, snus, and nicotine pouches. Although some toxic chemicals in e-cigarette aerosol appear lower than those in combustible cigarettes, device and liquid heterogeneity, the high addiction potential of nicotine salts, and the biological effects of flavorings sustain significant uncertainty regarding their true toxicological profile. Cohort studies and meta-analyses indicate that e-cigarette use does not increase smoking cessation success; rather, it promotes dual use and prolonged nicotine dependence. Among youth, e-cigarette use increases the likelihood of subsequent cigarette smoking by approximately 3.5–4 times, and passive exposure—especially among children—poses measurable health risks. Additionally, disposable e-cigarettes, lithium batteries, and mixed material components contribute to a growing source of electronic waste and environmental toxicity.

Current evidence does not support the widespread adoption of e-cigarettes as a reliable harm-reduction tool within tobacco control. Given the absence of product standardization, increased addiction risk, rising youth uptake, persistence of dual use, and mounting environmental burden, policy development should prioritize independent, methodologically robust evidence over industry-driven optimistic claims. Overall, the review highlights the need for precautionary regulatory approaches that prioritize youth protection, environmental safeguards, and independence from industry influence.

Keywords: electronic cigarettes, tobacco harm reduction, heated tobacco products, nicotine dependence, dual use, e-cigarette lung

References

  1. Perriot J, Chapot E, Peiffer G. Storia del fumo, del controllo del tabacco e della cura dei fumatori in Francia. Tabaccologia 2025; 23: 36-44. https://doi.org/10.53127/tblg-2025-A007
  2. Allbright K, Villandre J, Crotty Alexander LE, et al. The paradox of the safer cigarette: understanding the pulmonary effects of electronic cigarettes. Eur Respir J 2024; 63: 2301494. https://doi.org/10.1183/13993003.01494-2023
  3. Withington P, McShane A, Hinks J. Plague and intoxicants in the Baltic and North Seas during the Long Seventeenth Century. Continuity and Change: A Journal of Social Structure, Law and Demography in Past Societies 2025; 40: 309-338. Available at: https://eprints.whiterose.ac.uk/231554 https://doi.org/10.1017/s0268416025100817
  4. Glynn TJ, Hays JT, Kemper K. E-Cigarettes, harm reduction, and tobacco control: a path forward? Mayo Clin Proc 2021; 96: 856-862. https://doi.org/10.1016/j.mayocp.2020.11.022
  5. Besaratinia A. From tobacco cigarettes to electronic cigarettes: the two sides of a nicotine coin. Front Oral Health 2021; 2: 790634. https://doi.org/10.3389/froh.2021.790634
  6. World Health Organization (WHO). WHO report on the global tobacco epidemic 2021: addressing new and emerging products. Geneva: World Health Organization; 2021. Available at: https://www.who.int/publications/i/item/9789240032095
  7. Glasser AM, Collins L, Pearson JL, et al. Overview of electronic nicotine delivery systems: a systematic review. Am J Prev Med 2017; 52: e33-e66. https://doi.org/10.1016/j.amepre.2016.10.036
  8. Qureshi MA, Vernooij RWM, La Rosa GRM, Polosa R, O’Leary R. Respiratory health effects of e-cigarette substitution for tobacco cigarettes: a systematic review. Harm Reduct J 2023; 20: 143. https://doi.org/10.1186/s12954-023-00877-9
  9. Liber AC, Knoll M, Cadham CJ, et al. The role of flavored electronic nicotine delivery systems in smoking cessation: a systematic review. Drug Alcohol Depend Rep 2023; 7: 100143. https://doi.org/10.1016/j.dadr.2023.100143
  10. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf 2014; 5: 67-86. https://doi.org/10.1177/2042098614524430
  11. Burstyn I. Peering through the mist: systematic review of what the chemistry of contaminants in electronic cigarettes tells us about health risks. BMC Public Health 2014; 14: 18. https://doi.org/10.1186/1471-2458-14-18
  12. Nutt DJ, Phillips LD, Balfour D, et al. Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 2014; 20: 218-225. https://doi.org/10.1159/000360220
  13. Maziak W. Harm reduction at the crossroads: the case of e-cigarettes. Am J Prev Med 2014; 47: 505-507. https://doi.org/10.1016/j.amepre.2014.06.022
  14. Kathuria H, Leone FT. COUNTERPOINT: e-Cigarette use for harm reduction in tobacco use disorder? no. Chest 2021; 160: 809-811. https://doi.org/10.1016/j.chest.2021.04.044
  15. Seidenberg A, Kaufman A. ‘Tobacco-free’ claims in tobacco product marketing in the United States. Tob Control 2024; 33: 404-405. https://doi.org/10.1136/tc-2022-057700
  16. Ma S, Chaudhry E, Ahn S, et al. E-cigarette market proportion by nicotine claims in the United States. Prev Med Rep 2025; 54: 103087. https://doi.org/10.1016/j.pmedr.2025.103087
  17. Raymond BH, Collette-Merrill K, Harrison RG, Jarvis S, Rasmussen RJ. The nicotine content of a sample of e-cigarette liquid manufactured in the United States. J Addict Med 2018; 12: 127-131. https://doi.org/10.1097/ADM.0000000000000376
  18. Rashid RA, Adnan AN, Maasom S, Taylor G. Detection of nicotine in nicotine-free e-cigarette refill liquid using GC-MS. In: Proceedings of the Second International Conference on the Future of ASEAN (ICoFA) 2017 – Volume 2. Singapore: Springer; 2017: 615-624 https://doi.org/10.1007/978-981-10-8471-3_61
  19. Rashid R, Mohamed MH, Yusoff WSW. Detection of nicotine in nicotine-free e-cigarette refill liquid using GC-MS. Malays J Anal Sci 2019; 23: 415-421.
  20. Wu M, Heacock H, Tirado M, Shaw F. Presence of nicotine in marketed nicotine-free e-liquids for electronic cigarettes. BCIT Environ Public Health J 2017. https://doi.org/10.47339/ephj.2017.88
  21. Famele M, Ferranti C, Abenavoli C, Palleschi L, Mancinelli R, Draisci R. The chemical components of electronic cigarette cartridges and refill fluids: review of analytical methods. Nicotine Tob Res 2015; 17: 271-279. https://doi.org/10.1093/ntr/ntu197
  22. Morean ME, Wackowski OA, Eissenberg T, Delnevo CD, Krishnan-Sarin S, Gueorguieva R. Novel nicotine concentration labels improve adolescents’ and young adults’ understanding of the nicotine strength of electronic nicotine delivery system products. Nicotine Tob Res 2022; 24: 1110-1119. https://doi.org/10.1093/ntr/ntac024
  23. Ruggiero JL, Voller LM, Shaik JA, Hylwa S. Formaldehyde in electronic cigarette liquid (aerosolized liquid). Dermatitis 2022; 33: 332-336. https://doi.org/10.1097/DER.0000000000000771
  24. Gendall P, Hoek J. Role of flavours in vaping uptake and cessation among New Zealand smokers and non-smokers: a cross-sectional study. Tob Control 2021; 30: 108-110. https://doi.org/10.1136/tobaccocontrol-2019-055469
  25. Bahl V, Lin S, Xu N, Davis B, Wang YH, Talbot P. Comparison of electronic cigarette refill fluid cytotoxicity using embryonic and adult models. Reprod Toxicol 2012; 34: 529-537. https://doi.org/10.1016/j.reprotox.2012.08.001
  26. Centers for Disease Control and Prevention (CDC). Outbreak of lung injury associated with the use of e-cigarettes or vaping products. 2019. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html
  27. Bates CD. POINT: e-Cigarette use for harm reduction in tobacco use disorder? Yes. Chest 2021; 160: 807-809. https://doi.org/10.1016/j.chest.2021.04.046
  28. BCC Research. The global e-cigarette market is expected to reach 47.5 billion by 2028. 2024. Available at: https://www.bccresearch.com/pressroom/fod/global-e-cigarette-market-expected-to-reach-475-billion-by-2028
  29. Wang TW, Gentzke AS, Creamer MR, et al. Tobacco product use and associated factors among middle and high school students - United States, 2019. MMWR Surveill Summ 2019; 68: 1-22. https://doi.org/10.15585/mmwr.ss6812a1
  30. Soneji S, Barrington-Trimis JL, Wills TA, et al. Association between initial use of e-cigarettes and subsequent cigarette smoking among adolescents and young adults: a systematic review and meta-analysis. JAMA Pediatr 2017; 171: 788-797. https://doi.org/10.1001/jamapediatrics.2017.1488
  31. Gandhi A, Lee CE, Beaumont AL, et al. The respiratory epithelium in the era of vaping: insights from in vitro, in vivo, and human studies. Eur Respir Rev 2025; 34: 240256. https://doi.org/10.1183/16000617.0256-2024
  32. Roxlau ET, Pak O, Hadzic S, et al. Nicotine promotes e-cigarette vapour-induced lung inflammation and structural alterations. Eur Respir J 2023; 61: 2200951. https://doi.org/10.1183/13993003.00951-2022
  33. Bonner E, Chang Y, Christie E, et al. The chemistry and toxicology of vaping. Pharmacol Ther 2021; 225: 107837. https://doi.org/10.1016/j.pharmthera.2021.107837
  34. Langel SN, Kelly FL, Brass DM, et al. E-cigarette and food flavoring diacetyl alters airway cell morphology, inflammatory and antiviral response, and susceptibility to SARS-CoV-2. Cell Death Discov 2022; 8: 64. https://doi.org/10.1038/s41420-022-00855-3
  35. Auschwitz E, Almeda J, Andl CD. Mechanisms of e-cigarette vape-induced epithelial cell damage. Cells 2023; 12: 2552. https://doi.org/10.3390/cells12212552
  36. Ramirez JEM, Karim ZA, Alarabi AB, et al. The JUUL e-cigarette elevates the risk of thrombosis and potentiates platelet activation. J Cardiovasc Pharmacol Ther 2020; 25: 578-586. https://doi.org/10.1177/1074248420941681
  37. Morris AM, Leonard SS, Fowles JR, Boots TE, Mnatsakanova A, Attfield KR. Effects of e-cigarette flavoring chemicals on human macrophages and bronchial epithelial cells. Int J Environ Res Public Health 2021; 18: 11107. https://doi.org/10.3390/ijerph182111107
  38. Durra A, Cherry C, Luo C, et al. Unflavored electronic cigarette exposure induces alterations in airway ciliary structure and function. Respir Res 2025; 26: 223. https://doi.org/10.1186/s12931-025-03302-w
  39. Kligerman S, Raptis C, Larsen B, et al. Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): evolving knowledge and remaining questions. Radiology 2020; 294: 491-505. https://doi.org/10.1148/radiol.2020192585
  40. Herman M, Tarran R. E-cigarettes, nicotine, the lung and the brain: multi-level cascading pathophysiology. J Physiol 2020; 598: 5063-5071. https://doi.org/10.1113/JP278388
  41. Sahu R, Shah K, Malviya R, et al. E-cigarettes and associated health risks: an update on cancer potential. Adv Respir Med 2023; 91: 516-531. https://doi.org/10.3390/arm91060038
  42. Pisinger C, Dagli E, Filippidis FT, et al. ERS and tobacco harm reduction. Eur Respir J 2019; 54: 1902009. https://doi.org/10.1183/13993003.02009-2019
  43. Hedman L, Galanti MR, Ryk L, Gilljam H, Adermark L. Electronic cigarette use and smoking cessation in cohort studies and randomized trials: a systematic review and meta-analysis. Tob Prev Cessat 2021; 7: 62. https://doi.org/10.18332/tpc/142320
  44. Hendlin YH, Vora M, Elias J, Ling PM. Financial conflicts of interest and stance on tobacco harm reduction: a systematic review. Am J Public Health 2019; 109: e1-e8. https://doi.org/10.2105/AJPH.2019.305106
  45. Kang DHP, Chen M, Ogunseitan OA. Potential environmental and human health impacts of rechargeable lithium batteries in electronic waste. Environ Sci Technol 2013; 47: 5495-5503. https://doi.org/10.1021/es400614y
  46. Roy JJ, Rarotra S, Krikstolaityte V, et al. Green recycling methods to treat lithium-ion batteries e-waste: a circular approach to sustainability. Adv Mater 2022; 34: e2103346. https://doi.org/10.1002/adma.202103346
  47. van de Ven JJMM, Yang Y, Abrahami ST. A closer look at lithium-ion batteries in E-waste and the potential for a universal hydrometallurgical recycling process. Sci Rep 2024; 14: 16661. https://doi.org/10.1038/s41598-024-67507-7
  48. Protano C, Avino P, Manigrasso M, et al. Environmental electronic vape exposure from four different generations of electronic cigarettes: airborne particulate matter levels. Int J Environ Res Public Health 2018; 15: 2172. https://doi.org/10.3390/ijerph15102172
  49. Rodriguez J, Silverstein D, Mutic A, Liang D, Peterson S, Yang I. Passive electronic cigarette vapor exposure in children: a systematic review. Biol Res Nurs 2026; 28: 110-130. https://doi.org/10.1177/10998004251357832

How to cite

Turan, A., & Erhan, Ç. (2026). E-cigarettes and the myth of harm reduction: A critical evidence review. Turkish Journal of Tobacco Control, 6(1), 52-62. https://doi.org/10.64511/TJTC.2026.44